Eli Lilly, the producer of Mounjaro/Zepound GLP-1 injections, recently announced promising results from clinical trials on a new form factor a GLP-1 pill that is taken orally
The results with semaglutide alone are encouraging and suggest a potential new treatment option for a group of patients who previously had very few. The Phase II trial followed about 700 adults with biopsy-confirmed MASH and moderate to advanced liver scarring, including participants who had already developed early cirrhosis
Wegovy is FDA-approved specifically for weight management, while Ozempic and Mounjaro are approved for type 2 diabetes but often prescribed off-label for weight loss
The benzyl alcohol load is sized for normal aseptic technique, not for surface contamination
However, it depends on the provider and plan
"But there will come a day when we no longer see these access barriers for GLP-1s."